Indian digital health startup MFine has launched a cancer screening feature on its app in partnership with oncology research and solutions provider Datar Cancer Genetics.
MFine users can now book a range of cancer diagnostic tests from Datar's EasyCheck.
EasyCheck is a non-invasive, radiation-free test for early cancer detection. It has three types of test: EasyCheck360 detects cancer from...
Trialjectory, a startup that matches cancer patients to clinical trials, announced Monday it had raised $20 million in Series A funding.
The round was led by Insight Partners, with participation from JAL Ventures, Contour Venture Partners, Rho Capital and TIA Ventures.
WHAT IT DOES
The company offers an AI-enabled platform where patients can input information about their type of cancer and...
Remote patient-monitoring company Athelas scored $132 million across two funding rounds, earning the startup unicorn status with a valuation of $1.5 billion.
General Catalyst and Tribe Capital each led one of the financing rounds. Other participants include Sequoia Capital, YCombinator, Greenoaks, Human Capital and Initialized Capital.
Athelas' flagship product, the Athelas One, uses a finger...
Home-based cancer care startup Reimagine Care scored $25 million in a Series A funding round led by Santé Ventures, Martin Ventures and LRVHealth.
Other investors participating include the CU Healthcare Innovation Fund, City of Hope, McKesson Ventures and Sable Investments.
WHAT IT DOES
The company partners with providers and health plans to coordinate care in the home to avoid unnecessary...
King's College London and global pharmaceutical company, GlaxoSmithKline (GSK), have formed a new five-year partnership to use AI to provide insight into why and how some patients respond to certain cancer treatments.
WHY IT MATTERS
The collaboration will use AI systems to build tools that will support clinical decision-making to help improve patient outcomes.
This move has resulted in the...
ConcertAI, a healthcare data science and AI company that focuses on oncology, is expanding its partnership with Janssen Research & Development to improve study design and diversify clinical trials.
The company, formerly known as Concerto HealthAI, said the collaboration will allow it to expand its data sources, move into disease states at earlier stages and provide more access to new...
Italian startup PatchAi has joined forces with pharma giant Roche to launch a digital solution for patients affected by oncological diseases.
PatchAi for Smart Health Companion (SHC) embeds a virtual assistant which engages patients through empathic conversations using artificial intelligence (AI) and machine learning.
Following a pilot of the platform in July last year, it is now available to...
Home-delivery pharmacy AllianceRx Walgreens Prime is jumping into the oncology space with its new clinical assessment feature that lets cancer patients digitally manage their self-administered therapies.
Specifically, the new feature lets patients with oncology conditions refill their prescriptions online as opposed to over the phone. The way it works is patients can log in to their account and...
A new oncology treatment company dubbed Spesana is emerging out of stealth mode with a new molecular diagnostic decision support tool.
The platform is able to take information from a number of sources and synthesize information for providers. The way it works is Spesana’s tech can collect molecular diagnostic reports and coordinate them with EHRs, prior authorizations, payer processing, approved...
Today One Drop announced a string of new deals with Bayer that could bring the digital diabetes-management company nearly $100 million in new funds.
The agreements include the closure of a Series C financing round led by the pharma giant, as well as $64 million in unspecified development commitments and potential commercial milestone payments.
Launched in late 2016, One Drop's wireless blood...
_8_26.jpeg?itok=5qFMCFxo "A piggy bank next to a stethoscope and a pile of coins")
.jpeg?itok=UZpRIE7y "The partnership aims to investigate the role genetics play in developing personalised cancer treatments.")
